Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin's Lymphoma(NHL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05840289
What this trial is testing

A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma

Who this might be right for
Aggressive B-Cell Non-Hodgkin Lymphoma
University Hospital, Geneva 94
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Ended earlyNCT02811679
What this trial is testing

Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Massachusetts General Hospital 13
Not applicableStudy completedNCT01043302
What this trial is testing

Multicenter Cross Sectional Study of Primary Intestine Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma of Intestine
Samsung Medical Center 545
Testing effectiveness (Phase 2)Ended earlyNCT02258529
What this trial is testing

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Who this might be right for
Follicular LymphomaSmall Lymphocytic Lymphoma
Gilead Sciences 10
Early research (Phase 1)Ended earlyNCT02706405
What this trial is testing

JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma+3 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00299494
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
B-Cell Lymphoma
Pfizer 119
Early research (Phase 1)Ended earlyNCT05618366
What this trial is testing

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma
Weill Medical College of Cornell University 3
Not applicableWithdrawnNCT05416554
What this trial is testing

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

Who this might be right for
Non Hodgkin Lymphoma
Stanford University
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT06486051
What this trial is testing

Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

Who this might be right for
Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+1 more
Malaghan Institute of Medical Research 60
Early research (Phase 1)WithdrawnNCT05037669
What this trial is testing

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableLooking for participantsNCT06813573
What this trial is testing

Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaDiffuse Large B-Cell Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT03401853
What this trial is testing

Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Follicular LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Washington 18
Testing effectiveness (Phase 2)Study completedNCT00005080
What this trial is testing

506U78 in Treating Patients With Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaRecurrent Adult T-cell Leukemia/Lymphoma+11 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Looking for participantsNCT06119685
What this trial is testing

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Who this might be right for
NHLMultiple MyelomaBlood Cancer+4 more
Indapta Therapeutics, INC. 128
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Next Page